```html

Lash Loss (Madarosis)

Overview

Madarosis is the medical term for loss of eyelashes (and sometimes eyebrows). It can affect a single eye, both eyes, or the entire lid margin. While occasional shedding of a few lashes is normal, true madarosis involves a noticeable thinning or complete absence of lashes and may be a sign of an underlying systemic or local problem.

Lash loss can affect anyone, but certain groups are more commonly impacted:

• Adults 30–60 years old: Auto‑immune disorders and thyroid disease peak in this age range.
• Children: Congenital forms, infections, or trauma can cause early‑onset madarosis.
• Women: Cosmetic practices (e.g., eyelash extensions, aggressive makeup removal) and hormonal fluctuations make women slightly more prone.

Exact prevalence is difficult to establish because madarosis is often reported as a symptom rather than a diagnosis. However, studies suggest that up to 15% of patients with alopecia areata develop eyelash loss, and 5–10% of individuals with hyper‑thyroidism notice lash thinning.

Symptoms

The clinical picture varies with the underlying cause. Common manifestations include:

• Partial or total loss of upper & lower eyelashes: May start at the outer or inner third of the lid.
• Eyebrow loss (often concurrent): Particularly in alopecia areata or hypothyroidism.
• Itching, burning, or tenderness: Frequently seen with inflammatory conditions (e.g., blepharitis, eczema).
• Redness or scaling of the eyelid margin: Sign of infection or seborrheic dermatitis.
• Skin changes around the eye: Hyperpigmentation, hypopigmentation, or scarring from previous trauma.
• Eye irritation or foreign‑body sensation: Loss of lashes reduces protection of the ocular surface.
• Associated systemic symptoms: Weight changes, heat/cold intolerance (thyroid disease), joint pain (rheumatoid arthritis), or recent fever (viral infection).

Causes and Risk Factors

Madarosis is rarely idiopathic; most cases have an identifiable trigger.

Local ocular or dermatologic conditions

• Blepharitis: Chronic inflammation of the lid margin can damage hair follicles.
• Seborrheic dermatitis: Yeast‑driven scaling that interferes with lash growth.
• Contact dermatitis: Allergic reaction to cosmetics, eyelash extensions, or preservatives.
• Trauma: Burns, sharp injuries, or repeated rubbing.
• Infections: Bacterial (e.g., Staphylococcus), viral (herpes simplex, varicella‑zoster), or fungal infections can cause folliculitis.
• Skin cancers: Basal cell carcinoma on the lid can destroy follicles.

Systemic diseases

• Alopecia areata: Auto‑immune attack on hair follicles, often involves lashes and eyebrows.
• Thyroid disorders: Both hyper‑ and hypothyroidism disrupt hair cycles.
• Systemic lupus erythematosus (SLE) & other connective‑tissue diseases: Vascular inflammation can lead to follicular loss.
• Iron‑deficiency anemia & malnutrition: Essential nutrients (iron, zinc, biotin) are required for keratin synthesis.
• Hormonal changes: Pregnancy, menopause, and androgen excess can influence lash density.
• Chemotherapy or radiation therapy: Cytotoxic agents target rapidly dividing cells, including hair follicles.

Medications & substances

• Topical or systemic corticosteroids (withdrawal can cause rebound loss).
• Retinoids (e.g., isotretinoin) – known to cause dry eye and lash shedding.
• Beta‑blockers and antiplatelet agents – rare reports of eyelash loss.
• Substance abuse (e.g., methamphetamine “crank” scratching of eyelids).

Risk factors

• History of autoimmune disease.
• Chronic ocular surface disease.
• Frequent use of waterproof mascara, eyelash curlers, or extensions.
• Poor nutrition or restrictive diets.
• Family history of alopecia areata or thyroid disease.

Diagnosis

Accurate diagnosis requires a systematic approach to differentiate between local and systemic etiologies.

Clinical evaluation

1. History – duration of loss, associated symptoms, cosmetic practices, systemic illnesses, medications, and family history.
2. Physical exam – inspection of eyelid margins, eyebrows, scalp hair, skin lesions, and any signs of systemic disease.

Diagnostic tests

• Slit‑lamp examination: Allows magnified view of lid margin, identifying blepharitis, scaling, or folliculitis.
• Skin scraping or culture: When infection is suspected, samples are sent for bacterial, fungal, or viral PCR.
• Blood work:
  • Thyroid panel (TSH, free T4).
  • Complete blood count (CBC) and iron studies.
  • Autoimmune panel – ANA, anti‑dsDNA, rheumatoid factor.
  • Vitamin D, zinc, and biotin levels if nutritional deficiency is possible.
• Biopsy: In rare refractory cases, a 4‑mm punch biopsy of the lid margin can differentiate scarring vs. non‑scarring alopecia.
• Imaging: Ultrasound or MRI if an underlying orbital tumor is suspected.

Treatment Options

Treatment is directed at the underlying cause and at stimulating regrowth. A multidisciplinary team—ophthalmology, dermatology, endocrinology—often provides the best outcomes.

Medications

• Topical corticosteroids: Low‑potency agents (hydrocortisone 1%) applied twice daily for 2–4 weeks reduce inflammation (e.g., blepharitis).
• Calcineurin inhibitors (tacrolimus 0.03% ointment): Steroid‑sparing option for chronic dermatitis.
• Intralesional corticosteroid injections: 0.5 mL of triamcinolone acetonide (5 mg/mL) into the lid margin can stimulate regrowth in alopecia areata‑related madarosis.
• Topical prostaglandin analogs (bimatoprost 0.03%): FDA‑approved for eyelash growth; results appear after 12–16 weeks. Used off‑label for madarosis with caution in patients with glaucoma.
• Systemic therapy for autoimmune disease:
  • Oral corticosteroids (short burst) for active SLE or severe alopecia areata.
  • Janus kinase (JAK) inhibitors (tofacitinib, ruxolitinib) have shown promise in refractory alopecia areata with lash regrowth in up to 60% of patients (see JAMA Dermatology 2020).
• Thyroid hormone replacement or antithyroid drugs: Normalizing TSH levels often reverses lash loss within 3–6 months.
• Nutritional supplementation: Iron, zinc, biotin (2.5 mg daily) and vitamin D (1,000–2,000 IU) when labs are deficient.

Procedural interventions

• Artificial eyelash application: Temporary cosmetic solution; use hypoallergenic glue and avoid nightly wear.
• Lash transplant: Autologous hair grafting (usually scalp hair) performed by specialized oculoplastic surgeons; limited data but reports of satisfactory cosmetic outcomes.
• Laser or intense pulsed light (IPL) therapy: Used for refractory meibomian gland dysfunction that contributes to blepharitis‑related madarosis.

Lifestyle & self‑care measures

• Gentle eyelid cleansing twice daily with a diluted baby shampoo or commercial lid scrub.
• Avoid harsh makeup removers; use oil‑based or micellar water and a soft cotton pad.
• Limit or eliminate eyelash extensions and curling tools.
• Protect eyes from wind, dust, and UV (sunglasses with wrap‑around frames).
• Maintain a balanced diet rich in protein, omega‑3 fatty acids, iron, and zinc.

Living with Lash Loss (Madarosis)

While the cosmetic impact can affect self‑esteem, most people adapt with simple strategies.

• Eye protection: Lubricating eye drops (artificial tears) and saline washes reduce irritation caused by reduced blinking protection.
• Makeup adaptations:
  • Use hypoallergenic, fragrance‑free mascaras.
  • Apply a thin line of eyeliner on the waterline rather than the lash line to create visual fullness.
  • Consider colored lash pads or “lash tattoos” (semi‑permanent micro‑pigmentation) performed by certified technicians.
• Emotional support: Counseling or support groups (e.g., Alopecia Areata Support Network) help address body‑image concerns.
• Regular follow‑up: Schedule visits every 3–6 months to monitor regrowth and adjust therapy.

Prevention

Many causes of madarosis are modifiable.

• Practice good lid hygiene; clean eyelids daily, especially if you have rosacea or blepharitis.
• Avoid chronic eye rubbing or aggressive makeup removal.
• Choose reputable salons for eyelash extensions and limit the duration to <12 weeks.
• Screen for thyroid disease and iron deficiency at routine health exams.
• Maintain a nutrient‑dense diet; consider a multivitamin if you have restrictive eating patterns.
• Report new systemic symptoms (weight change, fatigue, joint pain) promptly to a clinician.

Complications

If left untreated, madarosis may lead to:

• Increased ocular surface disease: Lack of lashes reduces protection from dust and microorganisms, raising the risk of conjunctivitis and keratitis.
• Corneal abrasions or ulcers: Particularly in severe blepharitis or when artificial lashes are poorly applied.
• Psychological impact: Anxiety, depression, and social withdrawal are reported in up to 30% of patients with noticeable eyelash loss (Dermatology Research and Practice, 2020).
• Scarring alopecia: Chronic inflammation can permanently destroy hair follicles, making regrowth impossible without surgery.

When to Seek Emergency Care

---

References:

• Mayo Clinic. “Alopecia areata.” https://www.mayoclinic.org/diseases-conditions/alopecia-areata/symptoms-causes/syc-20354070 (accessed June 2026).
• American Academy of Dermatology. “Blepharitis.” https://www.aad.org/public/diseases/eyelid-blepharitis (accessed June 2026).
• National Institutes of Health, National Library of Medicine. “Thyroid disease and hair loss.” https://pubmed.ncbi.nlm.nih.gov/30292814/ (2023).
• JAMA Dermatology. “Efficacy of Janus Kinase Inhibitors in Alopecia Areata.” 2020;156(3):345‑354.
• World Health Organization. “Micronutrient deficiencies.” https://www.who.int/health-topics/micronutrient-deficiencies (2022).
• Cleveland Clinic. “Eye care after eyelash extensions.” https://my.clevelandclinic.org/health/diseases/21348-eyelash-extensions (2023).

```